ARA290 (Cibinetide) 15mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
ARA290 (Cibinetide) is a small molecule peptide derived from the erythropoietin structure, primarily used for repairing nerve and vascular damage, with anti-inflammatory and tissue-regenerating effects.
Effects
Promotes nerve repair and regeneration; reduces neuroinflammation and pain; improves microcirculation and vascular function; protects retinal cells; anti-apoptotic and anti-oxidative stress
Usage
Usually reconstituted with sterile saline for subcutaneous injection; recommended dose is 2-4 mg daily, used cyclically (e.g., for 14 consecutive days); specific regimen should be adjusted according to medical advice
Suitable for
Patients with diabetic peripheral neuropathy; patients with neuropathic pain; patients with retinal ischemia or inflammatory diseases; patients with acute nerve injury
Not suitable for
Individuals allergic to ARA290 or any excipient; pregnant and breastfeeding women; patients with severe liver or kidney dysfunction
Ingredients
Active ingredient: ARA290 (Cibinetide); Excipients: mannitol, phosphate buffer, etc.
Storage
Lyophilized powder should be stored at -20°C, protected from light; after reconstitution, store at 2-8°C and use within 24 hours
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
